These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 29737265)

  • 1. Nanoparticle Based Treatment for Cardiovascular Diseases.
    Gupta P; Garcia E; Sarkar A; Kapoor S; Rafiq K; Chand HS; Jayant RD
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):33-44. PubMed ID: 29737265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances on nanoparticle-based therapies for cardiovascular diseases.
    Soumya RS; Raghu KG
    J Cardiol; 2023 Jan; 81(1):10-18. PubMed ID: 35210166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine in the Diagnosis and Treatment of Atherosclerosis-A Systematic Review.
    Vaidyanathan K; Gopalakrishnan S
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):119-131. PubMed ID: 28925905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine: A great boon for cardiac regenerative medicine.
    Choudhury P; Kandula N; Kosuru R; Adena SKR
    Eur J Pharmacol; 2024 Nov; 982():176969. PubMed ID: 39218342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for Treatment of Lung Cancer.
    Hussain S
    Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotherapeutics for the Treatment of Cancer and Arthritis.
    Patel P; Meghani N; Kansara K; Kumar A
    Curr Drug Metab; 2019; 20(6):430-445. PubMed ID: 30479211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.
    Pala R; Anju VT; Dyavaiah M; Busi S; Nauli SM
    Int J Nanomedicine; 2020; 15():3741-3769. PubMed ID: 32547026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into Targeted and Stimulus-Responsive Nanocarriers for Brain Cancer Treatment.
    Abousalman-Rezvani Z; Refaat A; Dehghankelishadi P; Roghani-Mamaqani H; Esser L; Voelcker NH
    Adv Healthc Mater; 2024 May; 13(12):e2302902. PubMed ID: 38199238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advancements in the cardiovascular drug carriers.
    Singh B; Garg T; Goyal AK; Rath G
    Artif Cells Nanomed Biotechnol; 2016; 44(1):216-25. PubMed ID: 25046615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRET as the tool for in vivo nanomedicine tracking.
    Kaeokhamloed N; Legeay S; Roger E
    J Control Release; 2022 Sep; 349():156-173. PubMed ID: 35779657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
    Luo MX; Hua S; Shang QY
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
    Chakraborty S; Dhakshinamurthy GS; Misra SK
    J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles and the blood coagulation system. Part I: benefits of nanotechnology.
    Ilinskaya AN; Dobrovolskaia MA
    Nanomedicine (Lond); 2013 May; 8(5):773-84. PubMed ID: 23656264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
    Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
    Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine: novel approaches in human and veterinary therapeutics.
    Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S
    Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.